Niagen Bioscience Statistics
Total Valuation
NAGE has a market cap or net worth of $495.75 million. The enterprise value is $434.67 million.
| Market Cap | 495.75M |
| Enterprise Value | 434.67M |
Important Dates
The next estimated earnings date is Tuesday, March 3, 2026, after market close.
| Earnings Date | Mar 3, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
NAGE has 80.09 million shares outstanding. The number of shares has increased by 10.80% in one year.
| Current Share Class | 80.09M |
| Shares Outstanding | 80.09M |
| Shares Change (YoY) | +10.80% |
| Shares Change (QoQ) | +0.44% |
| Owned by Insiders (%) | 29.40% |
| Owned by Institutions (%) | 39.80% |
| Float | 52.71M |
Valuation Ratios
The trailing PE ratio is 26.35 and the forward PE ratio is 27.07.
| PE Ratio | 26.35 |
| Forward PE | 27.07 |
| PS Ratio | 3.89 |
| Forward PS | 3.35 |
| PB Ratio | 7.00 |
| P/TBV Ratio | 7.04 |
| P/FCF Ratio | 23.44 |
| P/OCF Ratio | 23.16 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 21.65, with an EV/FCF ratio of 20.55.
| EV / Earnings | 21.28 |
| EV / Sales | 3.49 |
| EV / EBITDA | 21.65 |
| EV / EBIT | 22.52 |
| EV / FCF | 20.55 |
Financial Position
The company has a current ratio of 4.12, with a Debt / Equity ratio of 0.04.
| Current Ratio | 4.12 |
| Quick Ratio | 3.22 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | 0.14 |
| Debt / FCF | 0.14 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 38.90% and return on invested capital (ROIC) is 21.74%.
| Return on Equity (ROE) | 38.90% |
| Return on Assets (ROA) | 15.60% |
| Return on Invested Capital (ROIC) | 21.74% |
| Return on Capital Employed (ROCE) | 25.59% |
| Revenue Per Employee | $1.20M |
| Profits Per Employee | $196,433 |
| Employee Count | 104 |
| Asset Turnover | 1.61 |
| Inventory Turnover | 3.07 |
Taxes
In the past 12 months, NAGE has paid $823,000 in taxes.
| Income Tax | 823,000 |
| Effective Tax Rate | 3.87% |
Stock Price Statistics
The stock price has increased by +7.28% in the last 52 weeks. The beta is 2.35, so NAGE's price volatility has been higher than the market average.
| Beta (5Y) | 2.35 |
| 52-Week Price Change | +7.28% |
| 50-Day Moving Average | 6.63 |
| 200-Day Moving Average | 8.84 |
| Relative Strength Index (RSI) | 39.42 |
| Average Volume (20 Days) | 839,527 |
Short Selling Information
The latest short interest is 5.67 million, so 7.08% of the outstanding shares have been sold short.
| Short Interest | 5.67M |
| Short Previous Month | 5.59M |
| Short % of Shares Out | 7.08% |
| Short % of Float | 10.77% |
| Short Ratio (days to cover) | 7.33 |
Income Statement
In the last 12 months, NAGE had revenue of $124.71 million and earned $20.43 million in profits. Earnings per share was $0.23.
| Revenue | 124.71M |
| Gross Profit | 79.68M |
| Operating Income | 19.30M |
| Pretax Income | 21.25M |
| Net Income | 20.43M |
| EBITDA | 20.08M |
| EBIT | 19.30M |
| Earnings Per Share (EPS) | $0.23 |
Balance Sheet
The company has $64.14 million in cash and $3.06 million in debt, with a net cash position of $61.08 million or $0.76 per share.
| Cash & Cash Equivalents | 64.14M |
| Total Debt | 3.06M |
| Net Cash | 61.08M |
| Net Cash Per Share | $0.76 |
| Equity (Book Value) | 70.68M |
| Book Value Per Share | 0.88 |
| Working Capital | 70.90M |
Cash Flow
In the last 12 months, operating cash flow was $21.41 million and capital expenditures -$260,000, giving a free cash flow of $21.15 million.
| Operating Cash Flow | 21.41M |
| Capital Expenditures | -260,000 |
| Free Cash Flow | 21.15M |
| FCF Per Share | $0.26 |
Margins
Gross margin is 63.89%, with operating and profit margins of 15.48% and 16.38%.
| Gross Margin | 63.89% |
| Operating Margin | 15.48% |
| Pretax Margin | 17.04% |
| Profit Margin | 16.38% |
| EBITDA Margin | 16.10% |
| EBIT Margin | 15.48% |
| FCF Margin | 16.96% |
Dividends & Yields
NAGE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -10.80% |
| Shareholder Yield | -10.80% |
| Earnings Yield | 4.12% |
| FCF Yield | 4.27% |
Analyst Forecast
The average price target for NAGE is $16.33, which is 163.81% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $16.33 |
| Price Target Difference | 163.81% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | 22.71% |
| EPS Growth Forecast (5Y) | 55.47% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on April 13, 2016. It was a reverse split with a ratio of 1:3.
| Last Split Date | Apr 13, 2016 |
| Split Type | Reverse |
| Split Ratio | 1:3 |
Scores
NAGE has an Altman Z-Score of 13.96 and a Piotroski F-Score of 6.
| Altman Z-Score | 13.96 |
| Piotroski F-Score | 6 |